Clinical Trials Logo

Colon Adenoma clinical trials

View clinical trials related to Colon Adenoma.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05275556 Completed - Colon Polyp Clinical Trials

Gastroenterology Artificial INtelligence System for Detecting Colorectal Polyps (The GAIN Study)

GAIN
Start date: March 1, 2022
Phase: N/A
Study type: Interventional

This is a prospective, multicenter, randomized controlled study to evaluate the effect of the Computer-Assisted Detection (CADe) Device on Adenomas Per Colonoscopy and Positive Percent Agreement for routine colonoscopies. The control arm is colonoscopy performed with High Definition White Light Endoscopy (HD-WLE) per standard of care. The intervention arm is colonoscopy performed with HD-WLE per standard of care plus the Computer-Assisted Detection (CADe) Device.

NCT ID: NCT04497935 Completed - Colon Cancer Clinical Trials

Comparison of Two Preparations for the Study of the Colon Through Colonoscopy

Start date: January 1, 2019
Phase:
Study type: Observational

Compare the quality of bowel preparation between two groups of patients, who will undergo two different preparations: 1. Moviprep + diet; 2. Plenvu + diet

NCT ID: NCT04294355 Completed - Colon Polyp Clinical Trials

Artificial Intelligence-assisted Colonoscopy on Detection of Missed Proximal Lesions

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

This is a prospective multi-center randomized study is to determine whether the use of artificial intelligence (AI)-assistance could reduce the miss rates of polyps and adenomas in the proximal colon during tandem examination

NCT ID: NCT04227795 Completed - Colon Cancer Clinical Trials

AI-assisted Detection of Missed Colonic Polyps

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

A prospective validation of real time deep learning artificial intelligence model for detection of missed colonic polyps

NCT ID: NCT03979690 Completed - Colorectal Cancer Clinical Trials

Feasibility Study of a Novel Single Use Robotic Colonoscopy System

Start date: June 12, 2019
Phase: N/A
Study type: Interventional

This is a single centre, non-randomized, tandem colonoscopy trial of the NISInspire-C System, followed immediately by a conventional colonoscope (CC). Each trial subject will undergo colonoscopy using the NISInspire-C system, followed immediately by CC. The purpose of this study is to obtain observational data on the safety profile, feasibility and usability of the NISInspire-C System in performing diagnostic colonoscopy in human subjects. The level of procedural pain experienced by subjects will also be explored.

NCT ID: NCT03949777 Completed - Colon Cancer Clinical Trials

Validation of Aer-O-Scope Colonoscope System Cecal Intubation

Start date: January 6, 2020
Phase: N/A
Study type: Interventional

61 subjects (male or female) between the ages of 45 and 75 will undergo colonoscopy. The primary outcome is Cecal Intubation

NCT ID: NCT03922074 Completed - Colo-rectal Cancer Clinical Trials

Outcomes of Colonoscopy With Non-anesthesiologist Administered Propofol

ADR_NAAP
Start date: January 2, 2017
Phase: N/A
Study type: Interventional

The Efficacy and safety of Non-anesthesiologist administered propofol (NAAP) for gastrointestinal endoscopy have been widely documented although there is not information which has evaluated the outcomes of colonoscopy it self when the endoscopist has to fulfill the additional task of supervising the sedation. Objective: To determine the equivalence of adenoma detection rate (ADR) in colorectal cancer (CRC) screening colonoscopies performed with NAAP and performed with monitored anesthesia care (MAC). Method: Single blind non-randomized controlled equivalence trial. Patients: Adults between 50 - 69 years old from National CRC screening program (CRCSP). Intervention: The patients are blindly assigned to undergo either colonoscopy with NAAP or MAC according to the arrival of fecal occult blood test, patient's suitability for colonoscopy date and availability of places at endoscopy schedule (with NAAP or MAC).

NCT ID: NCT03919487 Completed - Colon Adenoma Clinical Trials

Surrogate Quality Indicators for Adenoma Detection Rate (ADR)

Start date: July 1, 2018
Phase:
Study type: Observational

This study is to evaluate the correlation of adenoma missing rate and quality indicators of colonoscopy including adenoma detection ratee (ADR), polyp detection rate (PDR), adenoma per colonoscopy rate (APC), adenoma per positive participant (APP), ADR-Plus, and to find out the surrogate indicators of ADR. This study is a prospective observational multi-center study. Correlation between AMR and quality indicators of colonoscopy based on the previous studies, 8 endoscopists participated in this study and will enroll 50 screening colonoscopies respectively. Recruit research participants who want to participate in research in outpatient clinics. Perform colonoscopy in the morning after colon cleansing with split method. Colonoscopy is performed by back-to-back two consecutive colonoscopies. When the first colonoscopy is performed, the colonoscope is retracted after inserting the cecum, and all colon polyps are removed. After retracting to the anus of the first colonoscopy, the second colonoscopy is performed immediately. In case of newly detected colon polyps except for the small polyps and S-colon and rectal polyps which were left as photographs during the first colonoscopy with the second colonoscopy, we regard them as an overlooked lesion during the first colonoscopy. After the procedure, the histologic examination is confirmed and classified as benign lesions (all adenomas, advanced adenomas, dysplasia, and colorectal cancer) and non-lesion lesions. Using the back-to-back colonoscopy results of the participants during the study period, calculate the quality indicators including ADR, PDR, APC, ADR-plus, APP and AMR for each endoscopist. And then, evaluate the correlation between AMR and other quality indicators.

NCT ID: NCT03763266 Completed - Clinical trials for Inflammatory Bowel Diseases

Low Residue Diet During 3 Days vs 1 Day Prior Colonoscopy

Start date: December 6, 2018
Phase: N/A
Study type: Interventional

Colonoscopy is the gold-standard for the evaluation of the colorectal mucosa. Colonoscopy quality indicators are the adenoma detection rate, the rate of cecal intubation and the bowel preparation. The role of diet in preparing for colonoscopy is not fully established. Currently there is not enough evidence available to choice between 3 days of low residue diet versus 1 day. The research hypothesis is that the low residue diet offers a non-inferior bowel preparation and an improved tolerance.

NCT ID: NCT03742232 Completed - Colon Polyp Clinical Trials

Study Comparing the Bowel Cleansing Efficacy of PLENVU® Versus SELG-ESSE® Using a 2-Day Split Dosing Regimen.

Start date: October 31, 2018
Phase: Phase 4
Study type: Interventional

This study is a multicentre randomized parallel group phase IV study comparing the bowel cleansing efficacy, safety and tolerability of PLENVU® (a 1 litre PEG Bowel Cleansing Solution) versus SELG-ESSE® (a 4 litre PEG Bowel Cleansing Solution) using a 2-Day Split Dosing Regimen.